A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral Ixazomib (MLN9708) Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma
Sponsor: Takeda
A PHASE3 clinical study on Refractory Multiple Myeloma and Relapsed Multiple Myeloma, this trial is completed. The trial is conducted by Takeda and has accumulated 16 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Change History
16 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Apr 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Apr 2022 — Apr 2023 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Jan 2022 — Apr 2022 [monthly]
Active Not Recruiting PHASE3
▶ Show 11 earlier versions
-
Dec 2021 — Jan 2022 [monthly]
Active Not Recruiting PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Active Not Recruiting PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
-
Dec 2019 — Nov 2020 [monthly]
Active Not Recruiting PHASE3
-
Nov 2018 — Dec 2019 [monthly]
Active Not Recruiting PHASE3
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting PHASE3
-
Sep 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
-
Aug 2017 — Sep 2017 [monthly]
Active Not Recruiting PHASE3
-
May 2017 — Aug 2017 [monthly]
Active Not Recruiting PHASE3
-
Feb 2017 — May 2017 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Aug 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Takeda
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Anaheim, United States, Berkeley, United States, Boston, United States, Buffalo, United States, Calgary, Canada, Charleston, United States, Chicago, United States, Edmonton, Canada, Fayetteville, United States, Gainesville, United States and 13 more location s